The name’s Bond, seriously: 007’s namesake found in Polish Cold War archives

FAN Editor

September 23, 2020

WARSAW (Reuters) – Poles were left shaken and stirred by news that a suspected British agent called James Bond was on Her Majesty’s secret service in the country in the 1960s, after the Institute of National Remembrance (IPN) posted about him on social media.

According to the institute’s archive James Bond came to Poland on Feb. 18, 1964 and was officially employed as an archivist for the British Embassy Military Attache. He soon came to the attention of Polish counter-intelligence officers.

“We know he was in Poland … in 1964 and 1965,” Marzena Kruk, director of the IPN’s archive, told Reuters.

“He travelled a bit around Poland … he liked women, the same as his literary namesake, but there is not even a word about Martini,” she said, referring to the fictional character’s favourite tipple. “However, there is information that he liked Polish beer.”

Bond was under strict surveillance, and visited the Bialystok and Olsztyn regions of northeastern Poland to try and “penetrate military facilities” in the Soviet satellite state, according to the files.

However, he was found not to have made contacts with Polish citizens, which would have had serious consequences for any Poles suspected of working with agents from the other side of the Iron Curtain.

The British agent 007 created by author Ian Fleming hit the silver screen in 1962 when actor Sean Connery played the character in the film “Dr. No”, leading some to suspect British spies may have been playing a joke on their Polish counterparts with their choice of pseudonym.

“Maybe it was a bit of fun with Polish counter-intelligence, maybe he had a sense of humour,” Kruk said.

(Reporting by Alan Charlish; Editing by Janet Lawrence)

Free America Network Articles

Leave a Reply

Next Post

U.S. health officials defend handling of pandemic policies at Senate hearing

September 23, 2020 NEW YORK (Reuters) – U.S. health officials on Wednesday defended their agencies against broad criticism of their handling of the novel coronavirus pandemic, telling a U.S. Senate committee that they were using science as their guide, not politics. The head of the U.S. Food and Drug Administration […]